These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20860875)

  • 1. Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response?
    Keating C; Tilbrook A; Kulkarni J
    Int J Neuropsychopharmacol; 2011 May; 14(4):553-66. PubMed ID: 20860875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
    Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
    J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.
    Millan MJ
    Neurotherapeutics; 2009 Jan; 6(1):53-77. PubMed ID: 19110199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis.
    Nemeroff CB; Owens MJ
    CNS Spectr; 2004 Jun; 9(6 Suppl 4):23-31. PubMed ID: 15181382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa.
    Lanfranco F; Gianotti L; Picu A; Giordano R; Daga GA; Mondelli V; Malfi G; Fassino S; Ghigo E; Arvat E
    Eur J Endocrinol; 2006 May; 154(5):731-8. PubMed ID: 16645021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R
    Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is increased antidepressant exposure a contributory factor to the obesity pandemic?
    Lee SH; Paz-Filho G; Mastronardi C; Licinio J; Wong ML
    Transl Psychiatry; 2016 Mar; 6(3):e759. PubMed ID: 26978741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
    J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol, moderated by age, is associated with antidepressant treatment outcome and memory improvement in Major Depressive Disorder: A retrospective analysis.
    Jain FA; Connolly CG; Reus VI; Meyerhoff DJ; Yang TT; Mellon SH; Mackin S; Hough CM; Morford A; Wolkowitz OM
    Psychoneuroendocrinology; 2019 Nov; 109():104386. PubMed ID: 31382170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of cortisol suppression at baseline predicts improvement in HPA axis function during antidepressant treatment.
    Scherf-Clavel M; Wurst C; Nitschke F; Stonawski S; Burschka C; Friess L; Unterecker S; Hommers L; Deckert J; Domschke K; Menke A
    Psychoneuroendocrinology; 2020 Apr; 114():104590. PubMed ID: 32006918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats.
    Jensen JB; Jessop DS; Harbuz MS; Mørk A; Sánchez C; Mikkelsen JD
    J Neuroendocrinol; 1999 Jun; 11(6):465-71. PubMed ID: 10336728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder.
    Ruhé HG; Khoenkhoen SJ; Ottenhof KW; Koeter MW; Mocking RJ; Schene AH
    Psychoneuroendocrinology; 2015 Feb; 52():261-71. PubMed ID: 25544738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antidepressants, stressors and the serotonin 1A receptor].
    Kirilly E; Gonda X; Bagdy G
    Neuropsychopharmacol Hung; 2015 Jun; 17(2):81-9. PubMed ID: 26192901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
    Stewart LQ; Roper JA; Young WS; O'Carroll AM; Lolait SJ
    Psychoneuroendocrinology; 2008 May; 33(4):405-15. PubMed ID: 18243568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single-dose sertraline on the hypothalamus-pituitary-adrenal system, autonomic nervous system, and platelet function.
    Ahrens T; Frankhauser P; Lederbogen F; Deuschle M
    J Clin Psychopharmacol; 2007 Dec; 27(6):602-6. PubMed ID: 18004127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.